Ernst Kubista
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting.
Journal: International journal of cancer
Published: August 23, 2013
Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers.
Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: January 19, 2012
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.
Journal: Breast cancer research : BCR
Published: September 28, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.
Journal: Breast (Edinburgh, Scotland)
Published: April 11, 2011
Factors influencing the identification rate of the sentinel node in breast cancer.
Journal: European journal of cancer care
Published: March 02, 2011
Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
Journal: Climacteric : the journal of the International Menopause Society
Published: January 14, 2011
Presence of intratumoral stem cells in breast cancer patients with or without BRCA germline mutations.
Journal: Current cancer drug targets
Published: November 06, 2010
Differential expression pattern of estrogen receptors, aromatase, and sulfotransferase in breast cancer tissue and corresponding lymph node metastases.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 17, 2010
Proteomics in mammary cancer research.
Journal: European journal of gynaecological oncology
Published: January 27, 2010
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 03, 2009
Last Updated: 09/26/2026